Feelings of “mistrust” and “scepticism” among medics about working with pharmaceutical firms is holding back industry’s potential to help transform NHS patient care, a report has warned.
The resources, skills and capacity of the life sciences sector could help “pump-prime changes in the NHS that many patients want to see and staff want to deliver”, according to independent think tank the King’s Fund.
